Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
New Hampshire will receive $29.5 million over 10 years from the Purdue Pharma settlement to fund prevention, treatment, and recovery programs.
Texas is developing a medical psilocybin program to treat depression, PTSD, and substance use disorders, with support from Trump's executive order and FDA fast-tracking.
FDA grants Fast Track designation to CS-1103, a first-in-class molecule that binds and clears fentanyl from the body, potentially revolutionizing overdose treatment.
The White House releases its 2026 National Drug Control Strategy, introducing controversial new surveillance tools and emphasizing faith-based approaches to addiction treatment.
Landmark settlement bans Sackler family from U.S. opioid sales permanently and delivers $7.4 billion for addiction treatment, prevention, and recovery over 15 years.
American Hospital Association urges federal investment in loan repayment and training programs to address severe provider shortages affecting 75% of rural health professional shortage areas.
Trump administration reverses harm reduction policy, prohibiting federal funds for drug testing supplies and sterile syringes while emphasizing abstinence-based recovery approaches.
NIH-funded trial shows GLP-1 drug combined with cognitive behavioral therapy significantly reduces heavy drinking days in patients with alcohol use disorder and obesity.
Trump administration's new drug control strategy includes national wastewater monitoring, artificial intelligence cargo screening, and expanded faith-based treatment options.